New York REIT (NYRT) vs. Biomed Realty Trust (BMR) Critical Review
New York REIT (NYSE: NYRT) and Biomed Realty Trust (NYSE:BMR) are both finance companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, risk, profitability, valuation, analyst recommendations, dividends and institutional ownership.
Valuation and Earnings
This table compares New York REIT and Biomed Realty Trust’s revenue, earnings per share (EPS) and valuation.
|Gross Revenue||Price/Sales Ratio||EBITDA||Earnings Per Share||Price/Earnings Ratio|
|New York REIT||$174.99 million||7.38||$52.35 million||($0.50)||-15.38|
|Biomed Realty Trust||N/A||N/A||N/A||N/A||N/A|
New York REIT has higher revenue and earnings than Biomed Realty Trust.
This table compares New York REIT and Biomed Realty Trust’s net margins, return on equity and return on assets.
|Net Margins||Return on Equity||Return on Assets|
|New York REIT||N/A||-5.71%||-2.70%|
|Biomed Realty Trust||18.98%||3.73%||2.07%|
This is a summary of current recommendations for New York REIT and Biomed Realty Trust, as reported by MarketBeat.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
|New York REIT||0||0||1||0||3.00|
|Biomed Realty Trust||0||0||0||0||N/A|
New York REIT presently has a consensus target price of $9.75, suggesting a potential upside of 26.79%. Given New York REIT’s higher possible upside, analysts plainly believe New York REIT is more favorable than Biomed Realty Trust.
Insider & Institutional Ownership
70.5% of New York REIT shares are held by institutional investors. 0.2% of New York REIT shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.
New York REIT beats Biomed Realty Trust on 5 of the 8 factors compared between the two stocks.
New York REIT Company Profile
New York REIT, Inc. is a real estate investment trust. The Company owns a portfolio of commercial real estate. The Company’s business is primarily conducted through New York Recovery Operating Partnership, L.P. As of December 31, 2016, the Company owned 19 properties, which aggregated 3.3 million rentable square feet. The Company holds interests in properties of various types, such as office, retail, hotel, parking and storage. The Company’s properties include Design Center, 416 Washington Street, 50 Varick Street, 1440 Broadway, One Worldwide Plaza, 256 West 38th Street, 229 West 36th Street, 333 West 34th Street, 367-387 Bleecker Street, 33 West 56th Street (garage) and 350 West 42nd Street.
Biomed Realty Trust Company Profile
BioMed Realty Trust, Inc. operates as a real estate investment trust (REIT). The Company is the parent company and general partner of BioMed Realty, L.P. The Company owns, acquires, develops, redevelops, leases and manages laboratory and office space for the life science industry. The Company’s tenants primarily include biotechnology and pharmaceutical companies, scientific research institutions, government agencies and other entities involved in the life science industry. The Company’s properties are located in markets, which has centers for scientific research, including Boston, San Francisco, San Diego, Maryland, New York, New Jersey, Pennsylvania, North Carolina, Seattle, Cambridge (the United Kingdom) and research parks located near or adjacent to universities and their related medical systems. The Company owns interests in properties comprising approximately 17.5 million rentable square feet.
Receive News & Ratings for New York REIT Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for New York REIT Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.